Development of Biodegradable Nanocarriers Loaded with a Monoclonal Antibody

Treatments utilizing monoclonal antibody therapeutics against intracellular protein-protein interactions in cancer cells have been hampered by several factors, including poor intracellular uptake and rapid lysosomal degradation. Our current work examines the feasibility of encapsulating monoclonal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gdowski, Andrew, Ranjan, Amalendu, Mukerjee, Anindita, Vishwanatha, Jamboor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346939/
https://www.ncbi.nlm.nih.gov/pubmed/25690029
http://dx.doi.org/10.3390/ijms16023990

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346939/
https://www.ncbi.nlm.nih.gov/pubmed/25690029
http://dx.doi.org/10.3390/ijms16023990

Ejemplares similares